Keywords: king, acquires, certain, rights, lilly, lorabid, pharmaceuticals

King acquires certain rights to Lilly's Lorabid

Article | 05 August 1999

Print This

King Pharmaceuticals has acquired the rights to Eli Lilly'santibiotic Lorabid (loracarbef) for the USA and Puerto Rico. Under the terms ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in